Skin Health and Disease · 2023 · 12 citations · 18 references
MedicineDermatologyCost-benefit AnalysisHealth EconomicsHealth Services ResearchHair DisordersSkin CareAlopecia DisordersHair RegrowthHousehold Income DistributionHousehold Income MeasurementPatient Financial Burden AnalysisWider Economic Impacts
Background: Alopecia areata (AA) can have a significant impact on wellbeing. Consequently, individuals with AA often seek treatments or products to promote hair regrowth or camouflage their hair loss that incur a financial cost to the individual. Objectives: The current study aimed to examine the direct financial burden of AA to understand the wider impact of the condition and the factors which influence spending on products and services. Methods: A total of 829 United Kingdom based participants completed an online survey. Demographic and condition-specific data were collected, alongside spending on AA-related products and services. Participants were asked about their use of products and services, the associated costs, how they financed these costs, and their household income to determine what percentage of income they spent on products and services. Results: Participants predominantly identified as female (85.9%), white (92.7%) with a mean age of 42.7 years and a median AA duration of 10.94 years. Female gender, Asian ethnicity, lower income, and worse AA symptoms predicted higher spend from income. Wigs were the most common product used and incurred the greatest cost (median £700). The highest cost for men was private dermatology services (median = £550). On average people spent 3% of their disposable income (prior to housing costs) on AA-related products and services. Conclusions: This study outlines the risk factors associated with higher financial burden from managing AA which require consideration by health providers, commissioners, and policy makers when designing services to support the wellbeing of people living with AA.
18
Gender differences in stress and coping styles
Personality and Individual Differences · 2004 · 1.9K citations
Daniel A. Newman · Organizational Research Methods · 2014 · 1.4K citations
Two Phase 3 Trials of Baricitinib for Alopecia Areata
New England Journal of Medicine · 2022 · 458 citations · Full text
Medicine, Dermatology, Pharmacology +12